Advanced search
Publication Cover
Leukemia & Lymphoma Volume 64, 2023 - Issue 6
Submit an article Journal homepage
190
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Olverembatinib in relapsed Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia: a study of 5 cases

Chunxiao Liua Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, PR China;b Zhejiang Provincial Key Laboratory of Hematologic Malignancy, Zhejiang University, Hangzhou, PR China;c Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, PR China;d Zhejiang University Cancer Center, Hangzhou, PR ChinaView further author information
,
Xiang Zhanga Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, PR China;b Zhejiang Provincial Key Laboratory of Hematologic Malignancy, Zhejiang University, Hangzhou, PR China;c Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, PR China;d Zhejiang University Cancer Center, Hangzhou, PR ChinaView further author information
,
Liping Maoa Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, PR China;b Zhejiang Provincial Key Laboratory of Hematologic Malignancy, Zhejiang University, Hangzhou, PR China;c Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, PR China;d Zhejiang University Cancer Center, Hangzhou, PR ChinaView further author information
,
Jiejing Qiana Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, PR China;b Zhejiang Provincial Key Laboratory of Hematologic Malignancy, Zhejiang University, Hangzhou, PR China;c Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, PR China;d Zhejiang University Cancer Center, Hangzhou, PR ChinaView further author information
,
Feng Xiaoa Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, PR China;b Zhejiang Provincial Key Laboratory of Hematologic Malignancy, Zhejiang University, Hangzhou, PR China;c Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, PR China;d Zhejiang University Cancer Center, Hangzhou, PR ChinaView further author information
,
Xiujin Yea Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, PR China;b Zhejiang Provincial Key Laboratory of Hematologic Malignancy, Zhejiang University, Hangzhou, PR China;c Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, PR China;d Zhejiang University Cancer Center, Hangzhou, PR ChinaView further author information
,
Juying Weia Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, PR China;b Zhejiang Provincial Key Laboratory of Hematologic Malignancy, Zhejiang University, Hangzhou, PR China;c Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, PR China;d Zhejiang University Cancer Center, Hangzhou, PR ChinaView further author information
,
Xingnong Yea Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, PR China;b Zhejiang Provincial Key Laboratory of Hematologic Malignancy, Zhejiang University, Hangzhou, PR China;c Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, PR China;d Zhejiang University Cancer Center, Hangzhou, PR ChinaView further author information
,
Jie Jina Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, PR China;b Zhejiang Provincial Key Laboratory of Hematologic Malignancy, Zhejiang University, Hangzhou, PR China;c Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, PR China;d Zhejiang University Cancer Center, Hangzhou, PR ChinaCorrespondence[email protected]
View further author information
&
Wenjuan Yua Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, PR China;b Zhejiang Provincial Key Laboratory of Hematologic Malignancy, Zhejiang University, Hangzhou, PR China;c Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, PR China;d Zhejiang University Cancer Center, Hangzhou, PR ChinaCorrespondence[email protected]
View further author information
 show all
Pages 1208-1211 | Received 29 Dec 2022, Accepted 25 Mar 2023, Published online: 17 Apr 2023
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
Click to increase image sizeClick to decrease image sizeFree first page

Author contributions

Wenjuan Yu and Xiang Zhang designed this study. Liping Mao, Jiejing Qian, Feng Xiao, Xiujin Ye, Juying Wei, and Xingnong Ye collected and provided the clinical materials. Chunxiao Liu and Xiang Zhang integrated the clinical materials displayed the data analysis. Chunxiao Liu and Xiang Zhang wrote the manuscript. Jie Jin and Wenjuan Yu provided advices for this study and revised the manuscript. Chunxiao Liu and Xiang Zhang should be considered as the equally first authors. All authors approved the manuscript.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Data availability statement

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

Additional information

Funding

This study was funded by the Natural Science Foundation of Zhejiang Province [LY21H080003], and the National Natural Science Foundation of China [81800199].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.